Navigation Links
Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC
Date:10/11/2007

ZUG, Switzerland, October 11 /PRNewswire/ -- The young Swiss biotech enterprise AMVAC AG has gained reinforcement from Prof. Michel Klein, one of the world's most renowned vaccine specialists. Prof. Klein, who was formerly Vice President of Science & Technology of the Aventis-Pasteur Group, will immediately assume directorship of the scientific sector of vaccine development at AMVAC AG. This distinguished vaccinologist has access to an outstanding network across one of the greatest growth markets and will make a critical contribution in AMVAC AG's product research and development. Along with the vaccine against bacterial vaginosis already approved in Hungary, Klein is focusing on the further development of a vaccine against prostate enlargement, for which the performance of a clinical phase III study has been approved. In addition, AMVAC AG is preparing new projects for indications unnamed until now. Official statements on more new projects in the pharmaceutical industry will be released in the coming weeks.

Melinda Karpati, CEO of AMVAC, AG says, "Being able to win Prof. Michel Klein is a great success for us and affirms not only AMVAC AG's executive? direction, but also the continued recognition that we have come to know on the part of experienced experts in the field of vaccine development. His global network and the tremendous experience that Prof. Michel Klein brings to AMVAC AG will help us develop novel prophylactic and immunotherapeutic products in the pharmaceutical industry. Our new CSO's 40-year career has included numerous scientific publications, distinctions and groundbreaking vaccine developments. He has developed the five-component acellular pertussis vaccine currently on the market, brought vaccines against PIV-3, RSV and flu to phase I/II trials, launched the cancer vaccine program of Aventis-Pasteur and performed more than 40 trials with several prototypes of prophylactic and therapeutic HIV vaccines in collaboration with the NIH, WRA
'/>"/>

SOURCE AMVAG AG
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Safe Internet requires total network security, prof. says
2. Daugherty becomes CTO of Great Lakes BioFuels
3. DataPod becomes BeInSync so you can, too
4. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
5. Historic observatory becomes hot property on Lake Geneva
6. State technology chief endorses IT audit recommendations
7. Fusion 2007: CA chief says IT complexity raises risk
8. Web-Based Learning Developed under new Chief Education Officer
9. UW-Madisons Beebe wins scientific award
10. Researchers say scientific reporting needs more perspective, less hype
11. Wisconsin stands at the center of scientific efforts to avert flu epidemics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Veridiam (www.veridiam.com) w...ompany category at the 2009 Workplace Excellence A...ociety for Human Resources Management and recogniz...ices. ,, Veridiam was one of nine winners, sele...es, honored at the recent awards ceremony. San Die...
(Date:11/20/2009)...OLM, November 20 Karolinska Develo...ent Fund (EIF) has entered into a,co-investment ag...ill be,managed by Karolinska Development and used ...e pharmaceutical and medical technology companies....nvestment fund. The agreement,represents EIF,s lar...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domini...he Role of Process Analytical Technology (PAT) in ...cember 1, 2009. , (PRWEB)...ess Analytical Technology (PAT) in Green Chemistry...cess Analytical Technology (PAT) case studies will...
(Date:11/19/2009)...19 Omeros Corporation (N... results for the third quarter ended September 30,...09, Omeros reported a net loss of $3.9 million, or...4 million, or $2.54 per share, for the same period...2009, the Company reported a net loss of $15.5 mil...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...-Guided IMRT to Spare Healthy .... 16 Doctors at cancer,treatment centers in the U...head and neck cancer using RapidArc(TM) radiothera...VAR ). RapidArc was used to deliver ultra-precise,...T) significantly faster,than was previously possib...
...uticals, Inc. (Nasdaq: BCRX ) today announced tha...resident of BioCryst, will present,a corporate upd...e in New,York on Tuesday, September 23, 2008 at 2:... cast of the presentation may be accessed on,the B...esentation will be,archived for 30 days., About B...
... MIGENIX Inc. (the,"Company" or "MIGENIX") (TSX: M...gs for infectious diseases, reports financial resu...rovides a corporate update on its programs,and oth... Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; top...ted infections): Cadence Pharmaceuticals, Inc.,("C...
Other Biology Technology:Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 2Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 3BioCryst to Present at UBS 2008 Global Life Sciences Conference 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 2MIGENIX Reports First Quarter Fiscal 2009 Financial Results 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 4MIGENIX Reports First Quarter Fiscal 2009 Financial Results 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 6MIGENIX Reports First Quarter Fiscal 2009 Financial Results 7MIGENIX Reports First Quarter Fiscal 2009 Financial Results 8MIGENIX Reports First Quarter Fiscal 2009 Financial Results 9MIGENIX Reports First Quarter Fiscal 2009 Financial Results 10MIGENIX Reports First Quarter Fiscal 2009 Financial Results 11
(Date:11/20/2009)...s about the health benefits of having a life partn... where amino acids known as cysteines are much mor...d up with other cysteines. , Now, researchers at... in Belgium, have discovered a new antioxidant sys...ppears in the Nov. 20 issue of the journal Scienc...
(Date:11/20/2009)...tists from the Marine Biogeochemistry and Geology ...ratory (NRL) organized and led a team of universit...n to initiate methane hydrate exploration in the B... sediment contribution to Arctic climate change. ,... as a research platform, three cross-shelf transec...
(Date:11/20/2009)...ial gene into yeast, researchers from Delft Univer...ee improvements in bioethanol production from agri...te and elimination of the major by-product glycero...ientific journal Applied and Environmental Microb...the yeast Saccharomyces cerevisiae from sugars obt...
Breaking Biology News(10 mins):Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Delft breakthrough in bioethanol production from agricultural waste 2Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 1Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 2Advanced Instruments Introduces Next Generation Web Site 13665 1Advanced Instruments Introduces Next Generation Web Site 13665 2CareTech to Provide Web Services to Blessing Health System 55135 1CareTech to Provide Web Services to Blessing Health System 55135 2CareTech to Provide Web Services to Blessing Health System 55135 3CareTech to Provide Web Services to Blessing Health System 55135 4
...ter wi-fi, music over the internet, pitch percepti... favorite salmon, detecting dangerous swimmers, he...hm and movement disorders, visualizing the sound o...to save manatees from collisions with boats. , T...at the 156th meeting of the Acoustical Society of ...
...t Professor of Biomedical Engineering and Orthoped...oundation New Scholar in Aging by The Ellison Medi...s invited to nominate two faculty members to submi...ed for this award after an internal competition. N...s being granted out of 97 applicants. Dr. Alsberg ...
...screened known drugs and identified small molecule...nes, which can have dangerous side effects. This n... from fibroblasts, a general cell type that is abu...including skin. , The study was published in the ...e journal Cell Stem Cell. , "Our study shows fo...
Other Biology News:Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 3Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 4Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 5Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 6Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 7Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 8Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 9Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 10Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 11Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 12Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 13Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 14Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 15Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 16Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award 2Scripps research scientists identify compounds for stem-cell production from adult cells 2Scripps research scientists identify compounds for stem-cell production from adult cells 3
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Biology Products: